JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2007, 56(5):243-248

Mucoadhesive tablets for oral administration of ciclopiroxolamine

M. Kuna, M. Rabišková
Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav technologie léků

Oral mucoadhesive tablets belong to modern dosage forms, which allow controlled drug release after buccal application. They are used for the treatment of oral cavity disorders or for systemic administration of drugs with high first-pass effect or drugs instable in gastrointestinal tract. This study reports the development of oral mucoadhesive tablets containing antimycotic drug ciclopiroxolamine. Mucoadhesive properties of placebo tablets containing different ratios of carbomer and hydroxypropylmethylcellulose were evaluated in vivo in healthy human volunteers. The longest mucoadhesion for 9 hours was achieved in matrices containing 60 % (w/w) of carbomer. When optimum combination of the two mucoadhesive polymers was selected, tablets containing ciclopiroxolamine were prepared and one tablet side was film-coated to make the application procedure easier. Tablet quality parameters were determined and drug dissolution profile was evaluated under different pH conditions. In vitro release of ciclopiroxolamine was slower than the desintegration of prepared mucoadhesive tablets in vivo. Nevertheless, tablets containing 25 mg of ciclopiroxolamine performed prolonged drug release with oral mucosa concentrations higher than its MIC of relevant pathogens.

Keywords: mucoadhesion; tablet; carbomer; controlled release; ciclopiroxolamine

Received: June 13, 2007; Accepted: June 29, 2007; Published: May 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kuna M, Rabišková M. Mucoadhesive tablets for oral administration of ciclopiroxolamine. Čes. slov. farm. 2007;56(5):243-248.
Download citation

References

  1. Singla, A. K., Chawla M., Singh, A.: Drug Dev. Ind. Pharm., 2000; 26, 913-924. Go to original source... Go to PubMed...
  2. Smart, J. D.: Adv. Drug Del. Rev., 2005; 57, 1556-1568. Go to original source... Go to PubMed...
  3. Salamat-Miller, N., Chittchang, M., Johnston, T. P.: Adv. Drug Deliv. Rev., 2005; 57, 1666-1691. Go to original source... Go to PubMed...
  4. Dostálová, M., Rabišková, M.: Čes. a Slov. Farm., 2000; 2, 55-61.
  5. Rabišková, M., Sedláková, M., Vítková M., Kuna, M.: Čes. a Slov. Farm., 2004; 6, 300-303.
  6. Kauffman, C. A.: Proc. Am. Thorac. Soc., 2006; 3, 35-40. Go to original source... Go to PubMed...
  7. Carillo-Muñoz, A. J., Brió, S., Alonso, R. et al.: Int. J. Antimicrob. Agents, 2002; 20, 375-379. Go to original source... Go to PubMed...
  8. Tarawneh, R. T., Hamdan, I. I., Bani-Jaber, A., Darwish, R. M.: Int. J. Pharm., 2005; 289, 179-187. Go to original source... Go to PubMed...
  9. Český lékopis. Praha, Grada publishing, 2005, 7348 s.
  10. Batrafen, firemní prezentace. Frankfurt am Main, Hoechst Aktiengesellschaft Verkauf Pharma Ausland, 1982, 31s.
  11. Švihovec, J. et al.: Pharmindex kompendium. Praha, MediMedia Information, 2001, s. 293-294, 488-489.
  12. Grabovac, V., Guggi, D., Bernkop-Schnürch, A.: Adv. Drug Deliv. Rev., 2005; 57, 1713-1723. Go to original source... Go to PubMed...
  13. Nafee, N. A., Ismail, F. A., Boraie N. A., Mortada, L. M.: Drug Dev. Ind. Pharm., 2004; 30, 985-1004. Go to original source... Go to PubMed...
  14. Jadhav, B. K., Khandelwal, K. R., Ketkar, A. R., Pisal, S. S.: Drug Dev. Ind. Pharm., 2004; 30, 195-203. Go to original source... Go to PubMed...
  15. Rowe, R.C. et al.: Handbook of Pharmaceutical Excipients. 4. vyd. London, Pharmaceutical Press, s. 83-84.
  16. Shojaei, A. H.: J. Pharm. Pharm. Sci., 1998; 1, 15-30.
  17. Sudhakar, Y., Kuotsu, K., Bandyopadhyay, A. K.: J. Control. Release, 2006; 114, 15-40. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.